Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab
Altundag, K.
Journal of BUON Official Journal of the Balkan Union of Oncology 22(3): 801
2017
ISSN/ISBN: 1107-0625 PMID: 28730792 Document Number: 692235
Document emailed within 1 workday
Related Documents
Horiguchi, J.; Oyama, T.; Takata, D.; Rokutanda, N.; Nagaoka, R.; Odawara, H.; Tokiniwa, H.; Tozuka, K.; Kikuchi, M.; Sato, A.; Takeyoshi, I. 2011: Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience Anticancer Research 31(9): 3041-3046Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Wang, Y.; Li, J-jie.; Di, G-hong.; Lu, J-song.; Wu, J.; Liu, G-yu.; Hu, X-chun.; Wang, Z-hua.; Yang, W-tao.; Shao, Z-min. 2010: Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer Zhonghua Zhong Liu Za Zhi 32(11): 864-867
Olapade-Olaopa, E.O.; Moscatello, D.K.; MacKay, E.H.; Sandhu, D.P.S.; Terry, T.R.; Wong, A.J.; Habib, F.K. 2004: Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer African Journal of Medicine and Medical Sciences 33(3): 245-253
Murphy, C.G.; Fornier, M. 2010: HER2-positive breast cancer: beyond trastuzumab Oncology 24(5): 410-415
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820
Imai, Y.; Leung, C.K.; Friesen, H.G.; Shiu, R.P. 1982: Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture Cancer Research 42(11): 4394-4398
Tahover, E.; Sonnenblick, A.; Peretz, T.; Katz, D. 2012: Update: adjuvant trastuzumab in HER2 positive breast cancer Harefuah 151(1): 37-42 61
Robertson, K.W.; Reeves, J.R.; Smith, G.; Keith, W.N.; Ozanne, B.W.; Cooke, T.G.; Stanton, P.D. 1996: Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer Cancer Research 56(16): 3823-3830
Makino, H.; Iraha, M.; Manba, N.; Hashidate, H.; Shiotani, M. 2012: Utility of serum human epidermal growth factor receptor-2 extracellular domain(HER2 ECD)assessment in patients with advanced or recurrent breast cancer and those who received neoadjuvant therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 237-240
Rai, Y.; Sagara, Y.; Sagara, Y.; Takahama, T.; Matsuyama, Y.; Ando, M.; Sagara, Y.; Ooi, Y.; Inoue, K.; Kurosumi, M. 2007: Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(1): 65-68
Matsuoka, A.; Inoue, H.; Ogura, K.; Hattori, A.; Yukawa, H.; Sakaguchi, S.; Tanaka, N.; Kodera, A.; Kamimura, M.; Naritaka, Y.; Hirano, A. 2018: HER2-Positive Breast Cancer with Severe Infusion Reaction to Pertuzumab plus Trastuzumab-A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 1863-1865
Matsuda, T.; Fujita, H.; Kunimoto, Y.; Hosono, M.; Kimura, T.; Hayashi, T.; Maeda, T.; Yamakawa, J.; Maeda, N.; Mizumoto, T.; Maruyama, S.; Uenaka, Y.; Ogino, K. 2013: Successful ventilator weaning by trastuzumab in a HER2-positive breast cancer patient with multiple lung metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(6): 773-776
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Murayama, Y.; Mishima, Y. 1988: Effect of transforming growth factor-beta and epidermal growth factor on cell growth of human breast cancer Nihon Geka Gakkai Zasshi 89(2): 312
Gauthier, M.L.; Torretto, C.; Ly, J.; Francescutti, V.; O'Day, D.H. 2003: Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor Biochemical and Biophysical Research Communications 307(4): 839-846
Ying, J.-m.; Guo, L.; Liu, X.-y.; Qiu, T.; Lü, N. 2010: Automated silver-enhanced in situ hybridization detection assay for human epidermal growth factor receptor 2 gene status determination in breast cancer Zhonghua Yi Xue Za Zhi 90(24): 1674-1677
Foekens, J.A.; Portengen, H.; van Putten, W.L.; Trapman, A.M.; Reubi, J.C.; Alexieva-Figusch, J.; Klijn, J.G. 1989: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer Cancer Research 49(24 Part 1): 7002-7009
Christodoulou, C.; Klouvas, G.; Pateli, A.; Mellou, S.; Sgouros, J.; Skarlos, D.V. 2003: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer Anticancer Research 23(1b): 737-744
Hirano, T.; Sakurai, K.; Fujisaki, S.; Maeda, T.; Nagashima, S.; Hara, Y.; Tomita, R.; Suzuki, S.; Enomoto, K.; Amano, S. 2012: Lapatinib is useful for metastatic breast cancer patients who cannot be treated with trastuzumab-report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2045-2047